Ardevora Asset Management LLP Repligen Corp Transaction History

Ardevora Asset Management LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$161.19 - $257.96 $39.9 Million - $63.9 Million	-247,683 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$247.59 - $304.47 $5.79 Million - $7.12 Million	-23,400 Reduced 8.63%	247,683 $65.6 Million
Q3 2021 Oct 15, 2021	SELL	$194.77 - $324.21 $2.24 Million - $3.73 Million	-11,500 Reduced 4.07%	271,083 $78.3 Million
Q2 2021 Jul 22, 2021	BUY	$165.87 - $220.95 $4.09 Million - $5.45 Million	24,650 Added 9.56%	282,583 $56.4 Million
Q1 2021 Apr 22, 2021	SELL	$180.37 - $226.26 $5.84 Million - $7.33 Million	-32,377 Reduced 11.15%	257,933 $50.1 Million

Q4 2020 Jan 14, 2021	BUY	$148.08 - $206.57 $43 Million - $60 Million	290,310 New	290,310 $55.6 Million
Q2 2020 Jul 28, 2020	SELL	$94.33 - $140.48 $44.7 Million - $66.5 Million	-473,433 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$84.96 - $109.14 $40.2 Million - $51.7 Million	473,433 New	473,433 $45.7 Million
Q3 2019 Oct 25, 2019	SELL	$76.65 - $95.51 $42.4 Million - $52.8 Million	-552,877 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$54.2 - $85.95 $2.28 Million - $3.62 Million	-42,100 Reduced 7.08%	552,877 $47.5 Million
Q1 2019 Apr 24, 2019	SELL	$49.45 - $62.8 $845,595 - $1.07 Million	-17,100 Reduced 2.79%	594,977 $35.2 Million
Q4 2018 Jan 31, 2019	BUY	$48.26 - $68.88 $24.4 Million - $34.8 Million	505,020 Added 471.73%	612,077 $32.3 Million
Q3 2018 Oct 30, 2018	BUY	$46.8 - $58.97 $5.01 Million - $6.31 Million	107,057 New	107,057 $5.94 Million

522

53.2M

1.05M

228K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.66B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.